Frontiers in pharmacology · 2025
Menthol-thymol NADES as a fungicidal and chemosensitizing agent against multidrug-resistant Candida albicans: ROS induction, efflux pump inhibition, and synergy with fluconazole.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Negro Melisa Fabiana, Bustos Pamela Soledad, Bellezze Lautaro, Ortega María Gabriela, Echeverría Javier, Silva María Fernanda, Peralta Mariana Andrea
Аннотация
BACKGROUND: The increasing prevalence of azole-resistant Candida albicans (RCa) poses a critical therapeutic challenge, necessitating innovative antifungal approaches. Natural deep eutectic solvents (NADES), derived from natural metabolites such as terpenes, provide a promising and sustainable platform for delivering bioactive compounds with intrinsic pharmacological properties.
PURPOSE: This study evaluated a eutectic system composed of menthol and thymol (MT NADES, 1:1 M ratio) for its antifungal efficacy against a multidrug-resistant clinical C. albicans strain.
MATERIALS AND METHODS: The antifungal activity of MT NADES was evaluated against a clinical C. albicans strain resistant to azole antifungals (RCa). The minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) were determined using the broth microdilution method, following the CLSI M27-A4 guidelines. Synergistic effects with fluconazole were assessed through checkerboard microdilution and disc diffusion assays, with the fractional inhibitory concentration index (FICI) calculated to quantify interactions. Intracellular reactive oxygen species (ROS) levels were quantified using DCFH-DA staining and fluorescence spectrophotometry. Efflux pump inhibition was investigated via Nile red accumulation assay, analyzed by flow cytometry, using tacrolimus (100 µM) as a positive control. All experiments were performed in triplicate.
RESULTS AND DISCUSSION: MT NADES demonstrated potent fungicidal activity against resistant C. albicans with an MIC of 180 μg/mL and MFC of 360 μg/mL (MFC/MIC = 2), outperforming its components (menthol: 1000 μg/mL; thymol: 200 μg/mL). Synergistic interaction with fluconazole (MIC: 32 μg/mL) was confirmed by checkerboard and disc diffusion assays (FICI: 0.2839). Mechanistic studies revealed increased intracellular ROS, supporting oxidative stress as a key antifungal mechanism. Additionally, MT NADES at half its MIC enhanced Nile red retention 10-fold over the efflux pump inhibitor tacrolimus (100 µM), indicating strong inhibition of multidrug resistance (MDR)-related transporters. These findings highlight MT NADES as a promising chemosensitizing agent with superior efficacy over its individual components.
CONCLUSION: These findings underscore the therapeutic potential of menthol-thymol NADES as a multifunctional, plant-derived antifungal strategy capable of overcoming multidrug resistance mechanisms and potentiating azole efficacy in C. albicans.
PURPOSE: This study evaluated a eutectic system composed of menthol and thymol (MT NADES, 1:1 M ratio) for its antifungal efficacy against a multidrug-resistant clinical C. albicans strain.
MATERIALS AND METHODS: The antifungal activity of MT NADES was evaluated against a clinical C. albicans strain resistant to azole antifungals (RCa). The minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) were determined using the broth microdilution method, following the CLSI M27-A4 guidelines. Synergistic effects with fluconazole were assessed through checkerboard microdilution and disc diffusion assays, with the fractional inhibitory concentration index (FICI) calculated to quantify interactions. Intracellular reactive oxygen species (ROS) levels were quantified using DCFH-DA staining and fluorescence spectrophotometry. Efflux pump inhibition was investigated via Nile red accumulation assay, analyzed by flow cytometry, using tacrolimus (100 µM) as a positive control. All experiments were performed in triplicate.
RESULTS AND DISCUSSION: MT NADES demonstrated potent fungicidal activity against resistant C. albicans with an MIC of 180 μg/mL and MFC of 360 μg/mL (MFC/MIC = 2), outperforming its components (menthol: 1000 μg/mL; thymol: 200 μg/mL). Synergistic interaction with fluconazole (MIC: 32 μg/mL) was confirmed by checkerboard and disc diffusion assays (FICI: 0.2839). Mechanistic studies revealed increased intracellular ROS, supporting oxidative stress as a key antifungal mechanism. Additionally, MT NADES at half its MIC enhanced Nile red retention 10-fold over the efflux pump inhibitor tacrolimus (100 µM), indicating strong inhibition of multidrug resistance (MDR)-related transporters. These findings highlight MT NADES as a promising chemosensitizing agent with superior efficacy over its individual components.
CONCLUSION: These findings underscore the therapeutic potential of menthol-thymol NADES as a multifunctional, plant-derived antifungal strategy capable of overcoming multidrug resistance mechanisms and potentiating azole efficacy in C. albicans.